APSR2026-527

 
Regular
Submitted
Poster Presentation
 
AP08-008
P63
 
Format: PPTX Only
 
Format: PDF Only
06. Tuberculosis
8

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Wina Anggraeni * Faculty of Medicine Universitas Indonesia Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
Heidy Agustin - Faculty of Medicine Universitas Indonesia Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
Erlina Burhan - Faculty of Medicine Universitas Indonesia Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
Fathiyah Isbaniyah - Faculty of Medicine Universitas Indonesia Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
Diah Handayani - Faculty of Medicine Universitas Indonesia Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
Riyadi Sutarto - Faculty of Medicine Universitas Indonesia Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
Faiza Hatim - Faculty of Medicine Universitas Indonesia Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
Ibrahim Darmawan - Faculty of Medicine Universitas Indonesia Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
 
 
 
 
 
 
 
Presenting Author Details
Wina
Anggraeni
dr.wina1206@gmail.com
+6282218260432
31-40
Indonesia
Original Research
Profile of tuberculosis drug resistance patients and factors affecting treatment success at the national respiratory center, persahabatan hospital
Maximum 25 words
Abstract Content

The global success rate of tuberculosis (TB) treatment remains below target, particularly in drug-resistant TB (DR-TB). Identifying modifiable predictors of treatment success is essential to optimize outcomes. This study aimed to describe the clinical profile of DR-TB patients and determine factors associated with treatment success at a national referral respiratory center.

A retrospective cohort study was conducted using medical records of DR-TB patients treated at Persahabatan Hospital National Respiratory Center between 2022 and 2023. Demographic, clinical, and treatment-related variables were analyzed. Treatment outcomes were categorized according to standard definitions. Bivariate analysis was performed using the chi-square test, and odds ratios (OR) with 95% confidence intervals were calculated.

A total of 185 patients were included, with a mean age of 50.65±10.21 years; 58.4% were male. The majority had rifampicin-resistant TB (67%), followed by MDR-TB (22.7%) and XDR-TB (7.6%). Most patients received individualized regimens (67%), while 30.8% received short-course regimens. Treatment success (cured) was achieved in 61.6% of patients, while 15.1% experienced failure, 10.8% were lost to follow-up, and 12.5% died. Short-course regimens were significantly associated with higher treatment success (OR 1.92; p=0.045). Interestingly, unemployment was also independently associated with better outcomes (OR 2.85; p<0.001). HIV status and type of diabetes treatment were not significantly associated with treatment success.

In this study, DR-TB patients were predominantly older males with rifampicin resistance and moderate treatment success rates. Short-course regimens significantly improved outcomes, highlighting their potential as an effective strategy in programmatic settings. Socioeconomic factors, particularly employment status, also influenced treatment success, suggesting the need for tailored patient-centered interventions.

No
No
 
JPG or JPEG or PNG format ONLY
drug-resistant tuberculosis, treatment outcome, risk factors
maximum 3 keywords and no abbreviations, separated by commas
The authors declare no conflicts of interest. No external funding was received for this study.
272